AGENT FOR POSTOPERATIVE USE AFTER THE REMOVAL OF BONE TUMOURS

摘要

The invention relates to an agent for the production of a medicament which isused postoperatively after the removal of bone tumours. The inventive agent isproduced from a nucleic acid. A sequence known per se for promoting bonegrowth and a protease inhibitor also known per se are bonded by means of avariable spacer molecule. Said bonding results in a novel bifunctional activesubstance which combines both properties in one biological molecule. Theinvention is used in medecine, particularly in the specialist field oforthopaedics.